BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 33560342)

  • 1. G protein-coupled receptor kinase 5 (GRK5) contributes to impaired cardiac function and immune cell recruitment in post-ischemic heart failure.
    de Lucia C; Grisanti LA; Borghetti G; Piedepalumbo M; Ibetti J; Lucchese AM; Barr EW; Roy R; Okyere AD; Murphy HC; Gao E; Rengo G; Houser SR; Tilley DG; Koch WJ
    Cardiovasc Res; 2022 Jan; 118(1):169-183. PubMed ID: 33560342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiomyocyte-specific deficiency of HSPB1 worsens cardiac dysfunction by activating NFκB-mediated leucocyte recruitment after myocardial infarction.
    Wang Y; Liu J; Kong Q; Cheng H; Tu F; Yu P; Liu Y; Zhang X; Li C; Li Y; Min X; Du S; Ding Z; Liu L
    Cardiovasc Res; 2019 Jan; 115(1):154-167. PubMed ID: 29982352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determining the absolute requirement of G protein-coupled receptor kinase 5 for pathological cardiac hypertrophy: short communication.
    Gold JI; Gao E; Shang X; Premont RT; Koch WJ
    Circ Res; 2012 Sep; 111(8):1048-53. PubMed ID: 22859683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncovering G protein-coupled receptor kinase-5 as a histone deacetylase kinase in the nucleus of cardiomyocytes.
    Martini JS; Raake P; Vinge LE; DeGeorge BR; Chuprun JK; Harris DM; Gao E; Eckhart AD; Pitcher JA; Koch WJ
    Proc Natl Acad Sci U S A; 2008 Aug; 105(34):12457-62. PubMed ID: 18711143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GRK5 Controls SAP97-Dependent Cardiotoxic β
    Xu B; Li M; Wang Y; Zhao M; Morotti S; Shi Q; Wang Q; Barbagallo F; Teoh JP; Reddy GR; Bayne EF; Liu Y; Shen A; Puglisi JL; Ge Y; Li J; Grandi E; Nieves-Cintron M; Xiang YK
    Circ Res; 2020 Aug; 127(6):796-810. PubMed ID: 32507058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GRK5-mediated exacerbation of pathological cardiac hypertrophy involves facilitation of nuclear NFAT activity.
    Hullmann JE; Grisanti LA; Makarewich CA; Gao E; Gold JI; Chuprun JK; Tilley DG; Houser SR; Koch WJ
    Circ Res; 2014 Dec; 115(12):976-85. PubMed ID: 25332207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac-specific inducible overexpression of human plasma membrane Ca
    Sadi AM; Afroze T; Siraj MA; Momen A; White-Dzuro C; Zarrin-Khat D; Handa S; Ban K; Kabir MG; Trivieri MG; Gros R; Backx P; Husain M
    Clin Sci (Lond); 2018 Mar; 132(6):641-654. PubMed ID: 29487197
    [No Abstract]   [Full Text] [Related]  

  • 8. GRK2 blockade with βARKct is essential for cardiac β2-adrenergic receptor signaling towards increased contractility.
    Salazar NC; Vallejos X; Siryk A; Rengo G; Cannavo A; Liccardo D; De Lucia C; Gao E; Leosco D; Koch WJ; Lymperopoulos A
    Cell Commun Signal; 2013 Aug; 11():64. PubMed ID: 23984976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chemokine decoy receptor D6 prevents excessive inflammation and adverse ventricular remodeling after myocardial infarction.
    Cochain C; Auvynet C; Poupel L; Vilar J; Dumeau E; Richart A; Récalde A; Zouggari Y; Yin KY; Bruneval P; Renault G; Marchiol C; Bonnin P; Lévy B; Bonecchi R; Locati M; Combadière C; Silvestre JS
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2206-13. PubMed ID: 22796582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor 7 deficiency promotes survival and reduces adverse left ventricular remodelling after myocardial infarction.
    de Kleijn DPV; Chong SY; Wang X; Yatim SMJM; Fairhurst AM; Vernooij F; Zharkova O; Chan MY; Foo RSY; Timmers L; Lam CSP; Wang JW
    Cardiovasc Res; 2019 Oct; 115(12):1791-1803. PubMed ID: 30830156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FoxO4 promotes early inflammatory response upon myocardial infarction via endothelial Arg1.
    Zhu M; Goetsch SC; Wang Z; Luo R; Hill JA; Schneider J; Morris SM; Liu ZP
    Circ Res; 2015 Nov; 117(11):967-77. PubMed ID: 26438688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty acid-binding protein 3 contributes to ischemic heart injury by regulating cardiac myocyte apoptosis and MAPK pathways.
    Zhuang L; Li C; Chen Q; Jin Q; Wu L; Lu L; Yan X; Chen K
    Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H971-H984. PubMed ID: 30735072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GRK5 is a regulator of fibroblast activation and cardiac fibrosis.
    Eguchi A; Coleman R; Gresham K; Gao E; Ibetti J; Chuprun JK; Koch WJ
    Proc Natl Acad Sci U S A; 2021 Feb; 118(5):. PubMed ID: 33500351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
    Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
    Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction.
    Most P; Seifert H; Gao E; Funakoshi H; Völkers M; Heierhorst J; Remppis A; Pleger ST; DeGeorge BR; Eckhart AD; Feldman AM; Koch WJ
    Circulation; 2006 Sep; 114(12):1258-68. PubMed ID: 16952982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuraminidase-1 promotes heart failure after ischemia/reperfusion injury by affecting cardiomyocytes and invading monocytes/macrophages.
    Heimerl M; Sieve I; Ricke-Hoch M; Erschow S; Battmer K; Scherr M; Hilfiker-Kleiner D
    Basic Res Cardiol; 2020 Sep; 115(6):62. PubMed ID: 32975669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gi-biased β2AR signaling links GRK2 upregulation to heart failure.
    Zhu W; Petrashevskaya N; Ren S; Zhao A; Chakir K; Gao E; Chuprun JK; Wang Y; Talan M; Dorn GW; Lakatta EG; Koch WJ; Feldman AM; Xiao RP
    Circ Res; 2012 Jan; 110(2):265-74. PubMed ID: 22179058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonistic Roles of GRK2 and GRK5 in Cardiac Aldosterone Signaling Reveal GRK5-Mediated Cardioprotection via Mineralocorticoid Receptor Inhibition.
    Maning J; McCrink KA; Pollard CM; Desimine VL; Ghandour J; Perez A; Cora N; Ferraino KE; Parker BM; Brill AR; Aukszi B; Lymperopoulos A
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splenic Ly6C
    Tomczyk M; Kraszewska I; Szade K; Bukowska-Strakova K; Meloni M; Jozkowicz A; Dulak J; Jazwa A
    Basic Res Cardiol; 2017 Jul; 112(4):39. PubMed ID: 28534119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency of ataxia telangiectasia mutated kinase delays inflammatory response in the heart following myocardial infarction.
    Daniel LL; Daniels CR; Harirforoosh S; Foster CR; Singh M; Singh K
    J Am Heart Assoc; 2014 Dec; 3(6):e001286. PubMed ID: 25520329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.